Please use this identifier to cite or link to this item: https://dora.health.qld.gov.au/qldresearchjspui/handle/1/3235
Title: hPSC-Derived Enteric Ganglioids Model Human ENS Development and Function
Authors: Yu, J.
Goodarzi, H.
Nowakowski, T. J.
Majd, H.
Samuel, R. M.
Ramirez, J. T.
Kalantari, A.
Barber, K.
Ghazizadeh, Z.
Chemel, A. K.
Cesiulis, A.
Richter, M. N.
Das, S.
Keefe, M. G.
Wang, J.
Shiv, R. K.
McCann, C. J.
Bhat, S.
Khoroshkin, M.
Thapar, N. 
Fattahi, F.
Kaltschmidt, J. A.
Issue Date: 2022
Source: bioRxiv,no. (Majd H.; Samuel R.M.; Ramirez J.T.; Chemel A.K.; Cesiulis A.; Richter M.N.; Fattahi F., Faranak.Fattahi@ucsf.edu) Department of Cellular and Molecular Pharmacology, University of California, San Francisco, San Francisco, CA, United States, 2022
Journal Title: bioRxiv
Abstract: The enteric nervous system (ENS) plays a central role in gut physiology and mediating the crosstalk between the gastrointestinal (GI) tract and other organs. The human ENS has remained elusive, highlighting the need for an in vitro modeling and mapping blueprint. Here we map out the developmental and functional features of the human ENS, by establishing robust and scalable 2D ENS cultures and 3D enteric ganglioids from human pluripotent stem cells (hPSCs). These models recapitulate the remarkable neuronal and glial diversity found in primary tissue and enable comprehensive molecular analyses that uncover functional and developmental relationships within these lineages. As a salient example of the power of this system, we performed in-depth characterization of enteric nitrergic neurons (NO neurons) which are implicated in a wide range of GI motility disorders. We conducted an unbiased screen and identified drug candidates that modulate the activity of NO neurons and demonstrated their potential in promoting motility in mouse colonic tissue ex vivo. We established a high-throughput strategy to define the developmental programs involved in NO neuron specification and discovered that PDGFR inhibition boosts the induction of NO neurons in enteric ganglioids. Transplantation of these ganglioids in the colon of NO neuron-deficient mice results in extensive tissue engraftment, providing a xenograft model for the study of human ENS in vivo and the development of cell-based therapies for neurodegenerative GI disorders. These studies provide a framework for deciphering fundamental features of the human ENS and designing effective strategies to treat enteric neuropathies.L20168978712022-03-02
DOI: 10.1101/2022.01.04.474746
Resources: https://www.embase.com/search/results?subaction=viewrecord&id=L2016897871&from=exporthttp://dx.doi.org/10.1101/2022.01.04.474746 |
Keywords: nonhuman;animal cellanimal experiment;animal model;animal tissue;cell therapy;colon tissue;controlled study;engraftment;ex vivo study;gastrointestinal motility disorder;human;in vivo study;intestine innervation;male;mouse;nerve cell;neuropathy;nitrergic nerve cell;pluripotent stem cell;surgery;tumor xenograft;xenograft;endogenous compound;platelet derived growth factor receptor
Type: GEN
Appears in Sites:Children's Health Queensland Publications

Show full item record

Page view(s)

106
checked on Mar 20, 2025

Google ScholarTM

Check

Altmetric


Items in DORA are protected by copyright, with all rights reserved, unless otherwise indicated.